Daniel, Benjamin S; Borradori, Luca; Hall, Russell P; Murrell, Dédée F (2011). Evidence-based management of bullous pemphigoid. Dermatologic clinics, 29(4), pp. 613-20. Philadelphia, Pa.: Elsevier 10.1016/j.det.2011.06.003
Full text not available from this repository. (Request a copy)Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease typically affecting the elderly. Although different therapeutic regimens have been proposed, a review of the evidence is needed to aid clinicians in their decision making and management. Systemic therapies such as corticosteroids and adjuvants are effective in BP but are plagued with adverse effects, and potent topical steroids are an alternative treatment. This article reviews the evidence supporting different therapeutic options in the management of BP.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology |
UniBE Contributor: |
Borradori, Luca |
ISSN: |
0733-8635 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:21 |
Last Modified: |
05 Dec 2022 14:06 |
Publisher DOI: |
10.1016/j.det.2011.06.003 |
PubMed ID: |
21925006 |
Web of Science ID: |
000295755500013 |
URI: |
https://boris.unibe.ch/id/eprint/7052 (FactScience: 212201) |
Actions (login required)
 |
Edit item |